Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 47699 [2013-18857]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 151 / Tuesday, August 6, 2013 / Notices
Dated: August 1, 2013.
James R. Park,
Executive Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–18987 Filed 8–5–13; 8:45 am]
Office of the Secretary
BILLING CODE P
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
FEDERAL RESERVE SYSTEM
tkelley on DSK3SPTVN1PROD with NOTICES
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than August 30,
2013.
A. Federal Reserve Bank of San
Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. People’s Utah Bancorp, American
Fork, Utah; to acquire 100 percent of the
voting shares of Lewiston Bancorp, and
thereby indirectly acquire voting shares
of Lewiston State Bank, both in
Lewiston, Utah.
Board of Governors of the Federal Reserve
System, July 31, 2013.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2013–18857 Filed 8–5–13; 8:45 am]
BILLING CODE 6210–01–P
VerDate Mar<15>2010
19:47 Aug 05, 2013
Jkt 229001
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Pratima Karnik, Ph.D., Case Western
Reserve University: Based on the
admission of the Respondent, ORI found
that Dr. Pratima Karnik, Assistant
Professor, Department of Dermatology,
Case Western Reserve University
(CWRU), engaged in research
misconduct in research submitted to the
National Institute of Arthritis and
Musculoskeletal and Skin Diseases
(NIAMS), National Institutes of Health
(NIH), in grant application R01
AR062378.
ORI found that the Respondent
engaged in research misconduct by
plagiarizing significant portions from
research grant application R21
AR061881 that she had reviewed for
NIAMS, NIH, and inserting that text into
her submitted grant application R01
AR062378–01. Respondent also
plagiarized significant portions of text
from the following scientific articles and
one U.S. patent application available on
the Internet:
• BMC Med Genomics 4:8, 2011
• J Am Col. Cardiol 52:117–123, 2008
• Nature 457:910–914, 2009
• J Autoimmun 29:310–318, 2007
• U.S. Patent Application No.
20090047269 (published Feb. 19, 2009)
• Toxicol Pathol 35:952–957, 2007
• BMC Med Genomics 1:10, 2008
• Open Systems Biology Journal 1:1–
8, 2008
• Endocrinology 146:4189–4191,
2005.
•
Dr. Karnik has entered into a
Voluntary Settlement Agreement and
has voluntarily agreed for a period of
two (2) years, beginning on July 22,
2013:
(1) To have her research supervised;
Respondent agreed that prior to the
submission of an application for U.S.
Public Health Service (PHS) support for
a research project on which her
participation is proposed and prior to
her participation in any capacity on
PHS-supported research, Respondent
shall ensure that a plan for supervision
of her duties is submitted to ORI for
approval; the supervision plan must be
designed to ensure the scientific
SUMMARY:
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
47699
integrity of her research contribution;
she agreed that she shall not participate
in any PHS-supported research until
such a supervision plan is submitted to
and approved by ORI; Respondent
agreed to maintain responsibility for
compliance with the agreed upon
supervision plan;
(2) That any institution employing her
shall submit in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the content is free of
plagiarized material, data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived, and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) To exclude herself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
David E. Wright,
Director, Office of Research Integrity.
[FR Doc. 2013–18979 Filed 8–5–13; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day-13–13IF]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Pilot Project to Evaluate the Use of
Exposure Control Plans for Bloodborne
Pathogens in Private Dental Practices
–New- National Institute for
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 78, Number 151 (Tuesday, August 6, 2013)]
[Notices]
[Page 47699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18857]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than August 30, 2013.
A. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101 Market Street, San Francisco,
California 94105-1579:
1. People's Utah Bancorp, American Fork, Utah; to acquire 100
percent of the voting shares of Lewiston Bancorp, and thereby
indirectly acquire voting shares of Lewiston State Bank, both in
Lewiston, Utah.
Board of Governors of the Federal Reserve System, July 31, 2013.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2013-18857 Filed 8-5-13; 8:45 am]
BILLING CODE 6210-01-P
